ICLR
COM:ICONPLC
ICON plc
- Stock
184.48
−0.83%
−1.55
Company Overview
| Metric | ||||
|---|---|---|---|---|
| Company Name | ICON Public Limited Company | AGC Biologics | Applied Healthcare Research Management Inc. (AHRM) | DISSH |
| Symbol | ICLR | |||
| MSH ID | COM:ICONPLC | COM:AGCBIO | COM:AHRMINC | COM:DISSH |
| Market | STOCKS | PRIVATE | PRIVATE | PRIVATE |
| Sector | Healthcare | Healthcare & Health Services | Healthcare & Health Services | Consumer Goods |
| Industry | Medical - Diagnostics & Research | Biotechnology | Contract Research Organization (CRO) | Fashion |
| Country | IE | US | US | AU |
| Stage | ||||
| Employee Count | 41.15K | |||
| Website | iconplc.com | agcbio.com | ahrminc.com | dissh.com |
| applied-healthcare-resource-management | ||||
| Founders |
Market Metrics
| Metric | ||||
|---|---|---|---|---|
| Market Cap | 27.17B | |||
| Enterprise Value | ||||
| Monthly Web Traffic | 17.06K | 1 | 444.62K | |
| Web Traffic Growth | 0.56 | 0.14 | ||
| Valuation | ||||
| Raised Capital |
Financial Performance
| Metric | ||||
|---|---|---|---|---|
| Revenue | 8.12B | |||
| Revenue (LTM) | ||||
| Revenue (NTM) | ||||
| Gross Profit | 1.81B | |||
| EBITDA | 1.69B | |||
| Operating Income | 1.06B | |||
| Net Income | 612.34M | |||
| EPS | 7.46 | |||
| Diluted EPS | 7.40 | |||
| Revenue 2022 | ||||
| Revenue 2023 | ||||
| Revenue 2024 | ||||
| Revenue 2025 | ||||
| Revenue 2026 |
Growth Metrics
| Metric | ||||
|---|---|---|---|---|
| Revenue Growth (LTM) | ||||
| Revenue Growth (NTM) | ||||
| Gross Profit Growth (LTM) | ||||
| EBITDA Growth (LTM) | ||||
| Net Income Growth (LTM) | ||||
| 14-Day Growth Score | ||||
| 28-Day Growth Score | ||||
| 90-Day Growth Score | ||||
| 365-Day Growth Score |
Profitability Ratios
| Metric | ||||
|---|---|---|---|---|
| Gross Profit Margin | 0.28 | |||
| Operating Profit Margin | 0.13 | |||
| EBITDA Margin | 0.21 | |||
| Net Profit Margin | 0.09 | |||
| Return on Equity | 0.08 | |||
| Return on Assets | 0.04 | |||
| Return on Capital Employed | 0.08 |
Valuation Multiples
| Metric | ||||
|---|---|---|---|---|
| P/E Ratio | 42.50 | |||
| P/B Ratio | 2.44 | |||
| Revenue Multiple (LTM) | ||||
| Revenue Multiple (NTM) | ||||
| EBITDA Multiple (LTM) | ||||
| EBITDA Multiple (NTM) | ||||
| Price to Sales Ratio | 3.42 | |||
| EV Multiple | 14.63 |
Operational Metrics
| Metric | ||||
|---|---|---|---|---|
| Days Sales Outstanding | 134.60 | |||
| Days Payables Outstanding | 5.64 | |||
| Days Inventory Outstanding | 0.00 | |||
| Operating Cycle | 133.36 | |||
| Cash Conversion Cycle | 126.56 | |||
| Asset Turnover | 0.49 |
Cash Flow Metrics
| Metric | ||||
|---|---|---|---|---|
| Operating Cash Flow | 1.16B | |||
| Free Cash Flow | 1.02B | |||
| Cash Flow to Debt | 0.38 | |||
| Operating Cash Flow/Sales | 0.16 | |||
| Free Cash Flow Yield | 0.02 |
Balance Sheet Metrics
| Metric | ||||
|---|---|---|---|---|
| Cash & Equivalents | 378.10M | |||
| Accounts Receivable | -78.58M | |||
| Inventory | ||||
| Goodwill | 9.02B | |||
| Debt to Capitalization | 0.29 | |||
| Debt to Assets | 0.24 | |||
| Current Ratio | 1.19 | |||
| Quick Ratio | 1.31 |
Efficiency Metrics
| Metric | ||||
|---|---|---|---|---|
| Rule of 40 (LTM) | ||||
| Rule of 40 (NTM) | ||||
| Stock Comp to Revenue | 0.01 | |||
| R&D to Revenue | ||||
| SG&A to Revenue |